These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 12357516

  • 1. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE, Matthai WH, Cohen M, Moses JW, Hursting MJ, Leya F, ARG-216/310/311 Study Investigators.
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516
    [Abstract] [Full Text] [Related]

  • 2. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S.
    Am J Cardiovasc Drugs; 2009 Oct; 9(4):261-82. PubMed ID: 19655821
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators.
    Arch Intern Med; 2009 Oct; 163(15):1849-56. PubMed ID: 12912723
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ, Soffer J.
    Drug Saf; 2009 Oct; 32(3):203-18. PubMed ID: 19338378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Argatroban in the management of heparin-induced thrombocytopenia.
    Babuin L, Pengo V.
    Vasc Health Risk Manag; 2010 Sep 07; 6():813-9. PubMed ID: 20859550
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.
    Cruz-Gonzalez I, Sanchez-Ledesma M, Baron SJ, Healy JL, Watanabe H, Osakabe M, Yeh RW, Jang IK.
    J Thromb Thrombolysis; 2008 Apr 07; 25(2):214-8. PubMed ID: 17632689
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.
    Young G, Boshkov LK, Sullivan JE, Raffini LJ, Cox DS, Boyle DA, Kallender H, Tarka EA, Soffer J, Hursting MJ.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1103-9. PubMed ID: 21488155
    [Abstract] [Full Text] [Related]

  • 16. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR, Pietrangeli CE, Hursting MJ.
    Drugs Aging; 2007 Jul 01; 24(6):489-99. PubMed ID: 17571914
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL, Hursting MJ, McCollum D.
    Chest; 2006 May 01; 129(5):1167-75. PubMed ID: 16685006
    [Abstract] [Full Text] [Related]

  • 19. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
    Gray A, Wallis DE, Hursting MJ, Katz E, Lewis BE.
    Clin Appl Thromb Hemost; 2007 Oct 01; 13(4):353-61. PubMed ID: 17911186
    [Abstract] [Full Text] [Related]

  • 20. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM, McCollum DA, Hursting MJ.
    J Thromb Thrombolysis; 2006 Dec 01; 22(3):169-76. PubMed ID: 17103051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.